Naquotinib mesylate ( ASP-8273 )

Catalog No. M11914 CAS No. 1448237-05-5

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

Naquotinib mesylate
Note

Research use only, not for human use.
Brief Description

Naquotinib (ASP-8273) is a potent, irreversible, mutant-selective inhibitor of EGFR.
Description

Naquotinib (ASP-8273) is a potent, irreversible, mutant-selective inhibitor of EGFR (IC50=8-33 nM for (L858R, exon 19 deletion, L858R/T790M, and del19/T790M)); more potently than that of WT EGFR (IC50= 230 nM); shows activity in mutant EGFR cell line which is resistant to other EGFR TKIs including AZD9291 and CO-1686.Lung Cancer Phase 3 Clinical
Synonyms

ASP-8273
Pathway

Angiogenesis
Target

EGFR
Recptor

EGFR
Research Area

Cancer
Indication

Lung Cancer

CAS Number

1448237-05-5
Formula Weight

658.81
Molecular Formula

C31H46N8O6S
Purity

>98% (HPLC)
Solubility

DMSO: 12.5 mg/mL
SMILES

CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC5CCN(C5)C(=O)C=C.CS(=O)(=O)O
Chemical Name

2-Pyrazinecarboxamide, 6-ethyl-3-[[4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[[(3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]oxy]-, methanesulfonate (1:1)

1. Wang S, et al. J Hematol Oncol. 2016 Apr 12;9:34.

Calculator

molnova catalog